Results 161 to 170 of about 2,156 (171)

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status

Journal of Neuro-Oncology, 2006
M. Groves, V. Puduvalli, Charles A. Conrad, Mark R Gilbert, W. Yung, K. Jaeckle, V. Liu, Kenneth R. Hess, K. Aldape, Victor A. Levin   +9 more
semanticscholar   +1 more source

Marimastat randomised trial for advanced pancreatic cancer announced

The Lancet, 1996
openaire   +1 more source

Marimastat in the Treatment of Patients with Biochemically Relapsed Prostate Cancer: A Prospective Randomized, Double-Blind, Phase I/II Trial

Clinical Cancer Research, 2005
E. Rosenbaum, M. Zahurak, V. Sinibaldi, M. Carducci, R. Pili, M. Laufer, T. DeWeese, M. Eisenberger   +7 more
semanticscholar   +1 more source

Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model

Clinical and Experimental Metastasis, 2004
K. Maekawa, Hiroshi Sato, M. Furukawa, T. Yoshizaki   +3 more
semanticscholar   +1 more source

Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma

Clinical Endocrinology, 2001
Smit, J. W., van Tol, K. M., Hew, J. M., Vielvoye, G. J., Romijn, J. A., Links, T. P.   +5 more
openaire   +4 more sources

Mixed response to new data on anticancer agent marimastat

Inpharma Weekly, 1997
openaire   +1 more source

Differential effects between marimastat, a TNF-α converting enzyme inhibitor, and anti-TNF-α antibody on murine models for sepsis and arthritis

, 2002
F. Tsuji, K. Oki, A. Okahara, H. Suhara, T. Yamanouchi, M. Sasano, S. Mita, M. Horiuchi   +7 more
semanticscholar   +1 more source

A phase I clinical trial of the matrix metalloproteinase inhibitor, marimastat, administered concurrently with carboplatin, to patients with relapsed ovarian cancer

, 1997
H.C. Thomas, Melissa D. Adams
openalex   +1 more source

Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects.

, 2003
Julie King, Jing Zhao, P. Clingan, David L. Morris   +3 more
openalex  

Marimastat as Maintenance Therapy for Patients with Advanced Gastric and Gastro-oesophageal Cancer: A Randomised Trial.

, 2002
McCulloch P Maughan TBrown Pd Baillet M Fielding Jwl, RE Hawkins   +1 more
openalex